Skip to main content
Clinical Trials/NCT06531135
NCT06531135
Enrolling By Invitation
Not Applicable

A Randomized Controlled Trial of Psychosocial Interventions Facilitating Positive Psychological Adaptation in Patients With Breast Cancer

Koo Foundation Sun Yat-Sen Cancer Center1 site in 1 country200 target enrollmentNovember 23, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer Female
Sponsor
Koo Foundation Sun Yat-Sen Cancer Center
Enrollment
200
Locations
1
Primary Endpoint
posttraumatic growth by the PTGI
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

To test the effects of a 10-wk stress management interventions vs. a 5-wk control condition on positive psychosocial adaptation in women being treated for breast cancer. Participants assigned to either of the stress management groups will show better positive psychosocial adaptation compared to those in the control group.

Registry
clinicaltrials.gov
Start Date
November 23, 2021
End Date
December 31, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chihtao Cheng

Director, Psychiatric department, KFSYSCC, Taiwan

Koo Foundation Sun Yat-Sen Cancer Center

Eligibility Criteria

Inclusion Criteria

  • Aged between 20 and 70 years
  • Newly diagnosed breast cancer patients in stages I, II, or III (with no prior history of cancer)
  • Literate, without significant cognitive impairments
  • Capable of writing and expressing themselves in Chinese

Exclusion Criteria

  • Major psychiatric disorders (such as schizophrenia), personality disorders, and substance addiction (excluding smoking)
  • Currently participating in other breast cancer-related psychotherapy studies

Outcomes

Primary Outcomes

posttraumatic growth by the PTGI

Time Frame: Baseline (T1), post-intervention (T2), 6 months post-intervention (T3)

the PTGI a 21-item questionnaire each scored on a range of 0-5.

Distress by the HADS

Time Frame: Baseline (T1), post-intervention (T2), 6 months post-intervention (T3)

The HADS is a 14-item scale, with seven items relating to anxiety and seven relating to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.

Secondary Outcomes

  • Perceived Stress Management Abilities(Baseline (T1), post-intervention (T2), 6 months post-intervention (T3))
  • Quality of Life by the SF-36(Baseline (T1), post-intervention (T2), 6 months post-intervention (T3))
  • Positive and Negative affect(Baseline (T1), post-intervention (T2), 6 months post-intervention (T3))

Study Sites (1)

Loading locations...

Similar Trials